Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis

ABSTRACT Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the most malignant tumors of the digestive system. Emerging evidence suggests the involvement of the microbiome and metabolic substances in the development of PDAC, yet the results remain contradictory. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuan Fang, Xiaohong Liu, Jie Ren, Xing Wang, Feihan Zhou, Shi Huang, Lei You, Yupei Zhao
Format: Article
Language:English
Published: American Society for Microbiology 2024-11-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00962-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850151141001658368
author Yuan Fang
Xiaohong Liu
Jie Ren
Xing Wang
Feihan Zhou
Shi Huang
Lei You
Yupei Zhao
author_facet Yuan Fang
Xiaohong Liu
Jie Ren
Xing Wang
Feihan Zhou
Shi Huang
Lei You
Yupei Zhao
author_sort Yuan Fang
collection DOAJ
description ABSTRACT Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the most malignant tumors of the digestive system. Emerging evidence suggests the involvement of the microbiome and metabolic substances in the development of PDAC, yet the results remain contradictory. This study aims to identify the alterations and relationships in intratumoral microbiome and metabolites in PDAC. We collected matched tumor and normal adjacent tissue (NAT) samples from 105 PDAC patients and performed a 6-year follow-up. 2bRAD-M sequencing, untargeted liquid chromatography-tandem mass spectrometry, and untargeted gas chromatography-mass spectrometry were performed. Compared with NATs, microbial α-diversity decreased in PDAC tumors. The relative abundance of Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum was higher in PDAC tumor after adjusting for confounding factors body mass index and M stage, and the presence of Ralstonia pickettii_B was found associated with a worse overall survival. Metabolomic analysis revealed distinctive differences in composition between PDAC and NAT, with 553 discriminative metabolites identified. Differential metabolites were revealed to originate from the microbiota and showed significant interactions with shifted bacterial species through KO (KEGG Orthology) genes. These findings suggest that the PDAC microenvironment harbors unique microbial-derived enzymatic reactions, potentially influencing the occurrence and development of PDAC by modulating the levels of glycerol-3-phosphate, succinate, carbonate, and beta-alanine.IMPORTANCEWe conducted a large sample-size pancreatic adenocarcinoma microbiome study using a novel microbiome sequencing method and two metabolomic assays. Two significant outcomes of our analysis are: (i) commensal opportunistic pathogens Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum were enriched in pancreatic ductal adenocarcinoma (PDAC) tumors compared with normal adjacent tissues, and (ii) worse overall survival was found related to the presence of Ralstonia pickettii_B. Microbial species affect the tumorigenesis, metastasis, and prognosis of PDAC via unique microbe-enzyme-metabolite interaction. Thus, our study highlights the need for further investigation of the potential associations between pancreatic microbiota-derived omics signatures, which may drive the clinical transformation of microbiome-derived strategies toward therapy-targeted bacteria.
format Article
id doaj-art-778c71c31ea146c2904708e7dd471da3
institution OA Journals
issn 2165-0497
language English
publishDate 2024-11-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-778c71c31ea146c2904708e7dd471da32025-08-20T02:26:20ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972024-11-01121110.1128/spectrum.00962-24Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosisYuan Fang0Xiaohong Liu1Jie Ren2Xing Wang3Feihan Zhou4Shi Huang5Lei You6Yupei Zhao7Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaFaculty of Dentistry, The University of Hong Kong, Hong Kong SAR, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaABSTRACT Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the most malignant tumors of the digestive system. Emerging evidence suggests the involvement of the microbiome and metabolic substances in the development of PDAC, yet the results remain contradictory. This study aims to identify the alterations and relationships in intratumoral microbiome and metabolites in PDAC. We collected matched tumor and normal adjacent tissue (NAT) samples from 105 PDAC patients and performed a 6-year follow-up. 2bRAD-M sequencing, untargeted liquid chromatography-tandem mass spectrometry, and untargeted gas chromatography-mass spectrometry were performed. Compared with NATs, microbial α-diversity decreased in PDAC tumors. The relative abundance of Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum was higher in PDAC tumor after adjusting for confounding factors body mass index and M stage, and the presence of Ralstonia pickettii_B was found associated with a worse overall survival. Metabolomic analysis revealed distinctive differences in composition between PDAC and NAT, with 553 discriminative metabolites identified. Differential metabolites were revealed to originate from the microbiota and showed significant interactions with shifted bacterial species through KO (KEGG Orthology) genes. These findings suggest that the PDAC microenvironment harbors unique microbial-derived enzymatic reactions, potentially influencing the occurrence and development of PDAC by modulating the levels of glycerol-3-phosphate, succinate, carbonate, and beta-alanine.IMPORTANCEWe conducted a large sample-size pancreatic adenocarcinoma microbiome study using a novel microbiome sequencing method and two metabolomic assays. Two significant outcomes of our analysis are: (i) commensal opportunistic pathogens Staphylococcus aureus, Cutibacterium acnes, and Cutibacterium granulosum were enriched in pancreatic ductal adenocarcinoma (PDAC) tumors compared with normal adjacent tissues, and (ii) worse overall survival was found related to the presence of Ralstonia pickettii_B. Microbial species affect the tumorigenesis, metastasis, and prognosis of PDAC via unique microbe-enzyme-metabolite interaction. Thus, our study highlights the need for further investigation of the potential associations between pancreatic microbiota-derived omics signatures, which may drive the clinical transformation of microbiome-derived strategies toward therapy-targeted bacteria.https://journals.asm.org/doi/10.1128/spectrum.00962-24PDACpancreatic ductal adenocarcinomamicrobial metabolismmicrobiotametabolomecarcinogenesis
spellingShingle Yuan Fang
Xiaohong Liu
Jie Ren
Xing Wang
Feihan Zhou
Shi Huang
Lei You
Yupei Zhao
Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
Microbiology Spectrum
PDAC
pancreatic ductal adenocarcinoma
microbial metabolism
microbiota
metabolome
carcinogenesis
title Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
title_full Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
title_fullStr Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
title_full_unstemmed Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
title_short Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
title_sort integrated analysis of microbiome and metabolome reveals signatures in pdac tumorigenesis and prognosis
topic PDAC
pancreatic ductal adenocarcinoma
microbial metabolism
microbiota
metabolome
carcinogenesis
url https://journals.asm.org/doi/10.1128/spectrum.00962-24
work_keys_str_mv AT yuanfang integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT xiaohongliu integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT jieren integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT xingwang integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT feihanzhou integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT shihuang integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT leiyou integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis
AT yupeizhao integratedanalysisofmicrobiomeandmetabolomerevealssignaturesinpdactumorigenesisandprognosis